How does the BRCA1 mutation affect breast cancer treatment?

Question

Hi doctor,

I was diagnosed with breast cancer two months ago, and making treatment decisions has been overwhelming. It is invasive ductal carcinoma, grade 2, stage IIA. The tumor is 0.9 inches, with no lymph node involvement. It is estrogen receptor (ER) and progesterone receptor (PR) positive, and HER2 negative.

The oncologist has recommended a lumpectomy followed by chemotherapy and radiation. However, the genetic counselor identified a BRCA1 mutation in my family.

I am 41 years old, have two young children, and I am terrified. I am considering a bilateral mastectomy for peace of mind.

What would you recommend for breast cancer treatment in someone with a BRCA1 mutation? I am also very concerned about my daughters' future risk.

Please help me.

Thanks.

Answer 1

Hi,

Welcome to icliniq.com.

I can understand your concern.

I hope you are doing as well as possible given the circumstances. Thank you for sharing your story. I understand how overwhelming this time must feel. You have been diagnosed with stage IIA (invasive ductal carcinoma) invasive ductal carcinoma, estrogen receptor/progesterone receptor positive (ER/PR positive), human epidermal growth factor receptor 2 negative (HER2 negative) invasive ductal carcinoma and now also have a family history of a breast cancer gene 1 (BRCA1) mutation, which understandably raises complex treatment and future health questions.

First, from a treatment perspective:

The standard of care for your tumor (2.5 cm, node-negative, estrogen receptor/progesterone receptor positive [ER/PR positive]) typically involves a lumpectomy followed by radiation, and in some cases, chemotherapy, especially if the oncotype (genomic test to predict chemotherapy benefit) or other risk factors suggest benefit.

However, the breast cancer gene 1 (BRCA1) mutation significantly changes the risk landscape. BRCA1 is associated with a higher lifetime risk of developing a second breast cancer or ovarian cancer. For this reason, many BRCA1 carriers consider a bilateral mastectomy, even for early-stage cancer, as both a preventive and therapeutic measure.

In your case, a bilateral mastectomy may offer:

Peace of mind.
Elimination of future breast cancer risk.
Potential to avoid radiation (in some surgical plans).

Your care team should also discuss ovarian cancer risk, as BRCA1 increases this substantially. Long-term, this might involve a risk-reducing salpingo-oophorectomy (removal of fallopian tubes and ovaries), typically recommended between ages 35 and 45 after childbearing is complete.

As for your daughters, this is a valid concern. While genetic testing is not done before age 18, knowing your status allows for proactive planning. They should eventually receive genetic counseling to assess their own risk and consider early screening or preventive strategies if needed.

In summary:

A bilateral mastectomy is a very reasonable option given the breast cancer gene 1 (BRCA1) mutation, and many patients in your position make that choice.
There is no "wrong" answer, it depends on your values, peace of mind, family priorities, and discussions with your oncology and surgical teams.
It is also crucial to have support, whether through counseling, patient groups, or BRCA-focused resources, as you navigate decisions affecting both your health and your family's future.

Please do not hesitate to reach out if you want help reviewing your treatment plan or discussing your family’s risk further.

Thank you.